Nonopioid Analgesia After Anterior Cruciate Ligament Reconstruction

Completed · Phase 2/Phase 3

Conditions studied: Anterior Cruciate Ligament Injury

In brief

This is a randomized, single blinded, standard of care controlled clinical trial. This project aims to compare postoperative pain control in patients in two treatment arms of anterior cruciate ligament reconstruction: a treatment group given a nonopioid pain control regimen, and a standard of care control group given standard opioid pain control regimen

Key facts

Study ID

NCT03818932

Run by

Henry Ford Health System

People needed

90

Starts

2019-01-22

Expected to finish

2020-05-20

Last updated by the study team

2026-03-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• All adult patients over age 18 and scheduled for a primary or revision anterior cruciate ligament reconstruction

You may not qualify if…

• Exclusion criteria will include patients with a medical history of known allergies or intolerance to allergies or intolerance to Celebrex, Tylenol, Neurontin, dexamethasone, tramadol, substantial alcohol or drug abuse, and pregnancy, history of narcotics within 6 months of surgery, renal impairment, peptic ulcer disease, GI bleeding. Secondary exclusion criterion is an intact anterior cruciate ligament reconstruction

Where it is running

• Henry Ford Health System — Detroit, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.